Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Agile Therapeutics
Agile Therapeutics
(AGRX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Twirla
Ethinyl estradiol
,
Levonorgestrel
2020-02-14
2023-2039
Contraception
,
Breast neoplasms
,
Hot flashes
,
Hypogonadism
,
Menorrhagia
,
Premature menopause
,
Primary ovarian insufficiency
,
Prostatic neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ethinyl estradiol
ovulation inhibition
,
healthy volunteers/patients
,
contraception
Levonorgestrel
ovulation inhibition
,
healthy volunteers/patients
,
contraception
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use